Examples of using Third study in English and their translations into Croatian
{-}
-
Colloquial
-
Ecclesiastic
-
Computer
However, the third study found no difference between the effectiveness of DRAXXIN, oxytetracycline and placebo.
Međutim, trećim ispitivanjem nije dokazana razlika u djelotvornosti VMP-a Draxxin, oksitetraciklina i placeba.In two studies, it was compared with placebo, and the third study also compared it with oxytetracycline another antibiotic.
The third study was conducted to evaluate the pharmacodynamics and safety of different dose regimens of Aldurazyme.
Treće ispitivanje provedeno je u svrhu ocjenjivanja farmakodinamike i sigurnosti različitih režima doziranja lijeka Aldurazyme.Two studies assessed the effects of Invega on symptoms of mania whereas the third study assessed the effects on symptoms of depression.
Dva su A third study in 776 children compared the effects of M-M-RVAXPRO when given as injected into the muscle and when injected under the skin.
Treće ispitivanje u 776 djece uspoređivalo je učinke M-M-RVAXPRO kad se injektirao u mišić i kad se injektirao pod kožu.Two studies(studies 304 and 305) compared doses of perampanel 8 and12 mg/day with placebo and the third study(study 306) compared doses of perampanel 2, 4 and 8 mg/day with placebo.
Dva ispitivanja(ispitivanja 304 i 305) uspoređivala su doze perampanela od 8 i12 mg na dan s placebom, dok je treće ispitivanjeIn the third study in women weighing 50 kg or more, 24 and 27% of women treated with Elonva and follitropin beta respectively became pregnant.
U trećem ispitivanju u žena s 50 kg ili više, zatrudnjelo je 24 i 27% žena liječenih Elonvom, odnosno folitropinom beta.The efficacy and safety of a variation of the Zevalin therapeutic regimen employing a reduced dose of ibritumomab tiuxetan[90Y]was further defined in a third study enrolling a total of 30 patients who had mild thrombocytopenia platelet count 100,000 to 149,000 cells/mm3.
Djelotvornost i sigurnost varijante protokola u kojem se upotrebljavasmanjena doza ibritumomab tiuksetana[90Y] dodatno su utvrđene trećim ispitivanjem u kojem je sudjelovalo ukupno 30 bolesnika s blagom trombocitopenijom broj trombocita u rasponu od 100 000 do 149 000 stanica/mm3.In the third study, 17(61%) of the 28 patients responded to treatment with an improvement of at least one point on the disability scale.
U trećem ispitivanju, 17 od 28 bolesnika(61%) pozitivno je odgovorilo na liječenje, uz poboljšanje od najmanje jednog boda na ljestvici onesposobljenosti.The third study showed that the immune response triggered by M-M-RVAXPRO was the same regardless of whether it was injected into a muscle or under the skin.
Treće ispitivanje pokazalo je da je imunološki odgovor koji je potaknuo M-M-RVAXPRO isti bez obzira na to je li cjepivo injektirano u mišić ili pod kožu.A third study, which involved 900 adults aged 18 to 49, compared the immune response to Prevenar 13 with the response in adults aged 60 to 64.
Treće ispitivanje, koje je uključivalo 900 odraslih osoba u dobi od 18 do 49 godina, usporedilo je imunološki odgovor na lijek Prevenar 13 s odgovorom u odraslih osoba u dobi od 60 do 64 godine.In a third study, a pre-specified analysis demonstrated efficacy over placebo for 100 mg/day and 200 mg/day in patients with prior exposure to levetiracetam.
U trećem ispitivanju, unaprijed specificirana analiza dokazala je djelotvornost u odnosu na placebo za 100 mg/dan i 200 mg/dan u bolesnika koji su prethodno bili izloženi levetiracetamu.In the third study, after 8 weeks of treatment patients who took Kalydeco had an average improvement of 10.7 percentage points more than those who took placebo.
U trećem ispitivanju, nakon 8 tjedana terapije bolesnici koji su uzimali Kalydeco imali su prosječno poboljšanje za 10, 7 postotnih poena više u odnosu na osobe koje su uzimale placebo.The third study showed a significant decrease in seizure frequency only in patients taking 4 mg and 8 mg Fycompa but not in patients taking a dose of 2 mg.
U trećem ispitivanju utvrđeno je značajno smanjenje učestalosti napada samo In a third study in adults aged 50-93 years, it was demonstrated that Prevenar 13 may be given concomitantly with the seasonal quadrivalent inactivated influenza vaccine QIV.
U trećem ispitivanju u odraslih u dobi od 50 do 93 godine dokazano je da se Prevenar 13 može davati istovremeno sa sezonskim četverovalentnim inaktiviranim cjepivom protiv gripe.A third study examined the use of Privigen for immunomodulation in 28 patients with CIDP who were given Privigen every three weeks over a period of 24 weeks.
U trećem ispitivanju ispitana je primjena lijeka Privigen za imunomodulaciju In the third study in adults with hepatitis B and decompensated liver disease, 70% of patients taking Viread or entecavir had a viral level below 400 copies/ml.
U trećem ispitivanju u odraslih osoba s hepatitisom B i dekompenziranom bolešću jetre, 70% bolesnika koji su uzimali lijekove Viread ili entecavir imalo je razinu virusa manju od 400 kopija/ml.In addition, a third study is ongoing in 5,623 patients where previous treatment with another disease-modifying therapy had failed glatiramer acetate, beta-interferon or fingolimod.
Osim toga, trenutačno se provodi treće ispitivanje na 5 623 bolesnika koji su prethodno neuspješno liječeni terapijom koja mijenja tijek bolesti glatiramer acetat, beta-interferon ili fingolimod.In the third study, women taking Tyverb with trastuzumab lived without their disease getting worse for 12 weeks on average, compared with 8.1 weeks in those taking Tyverb alone.
U trećem ispitivanju, žene koje su uzimale Tyverb s trastuzumabom živjele su bez pogoršanja bolesti prosječno 12 tjedana, u usporedbi s 8, 1 tjednom u žena koje su uzimale monoterapiju lijekom Tyverb.In the second and third study, 2.3% and 5.9% of patients taking Nevanac 3 mg/ml developed macular oedema, respectively, compared with between 17.3% and 14.3% of patients taking placebo.
U drugom i trećem ispitivanju, 2, 3% odnosno 5, 9% bolesnika koji su uzimali lijek Nevanac jačine 3 mg/ml razvili su makularni edem, u usporedbi sa 17, 3% i 14, 3% bolesnika koji su uzimali placebo.In the third study, Zometa was as effective as pamidronate: 44% of the patients receiving Zometa had at least one skeletal event, compared with 46% of those receiving pamidronate.
U trećem ispitivanju, Zometa je bio djelotvoran kao pamidronat: 44% bolesnika koji su primili lijek Zometa imalo je najmanje jedan skeletalni poremećaj, u usporedbi sa 46% onih koji su primili pamidronat.A third study, D9902A, similar in design to study D9901, was terminated prior to completion of planned accrual based on the time to disease progression results in study D9901.
Treća studija, D9902A, sličnog dizajna kao In a third study in patients with cancer of the head and neck including mouth cancer, Lymphoseek was used to detect sentinel lymph nodes before patients had their lymph nodes removed surgically.
U trećem ispitivanju u bolesnika s rakom glave i vrata, uključujući i rak usta, lijek Lymphoseek korišten je za detekciju limfnih čvorova prije nego što su limfni čvorovi uklonjeni bolesnicima kirurškim putem.In a third study, Rixubis was given to 14 patients undergoing surgery; treatment with Rixubis kept blood loss during the surgery to levels expected in patients without haemophilia B.
U trećem ispitivanju, Rixubis je primijenjen na 14 bolesnika koji su podvrgnuti kirurškom zahvatu; terapija lijekom Rixubis zadržala je gubitak krvi tijekom kirurškog zahvata unutar razina očekivanih za bolesnike bez hemofilije B.In the third study, 334 patients received an injectable form of paliperidone for a mood episode for 6 months after which they either received placebo or continued treatment with injectable paliperidone.
U trećem ispitivanju, 334 bolesnika primila su oblik paliperidona koji se injektira za epizode raspoloženja tijekom 6 mjeseci nakon čega je svaki bolesnik primio placebo ili nastavio terapiju injektibilnim paliperidonom.A third study looked at 332 patients with complicated intra-abdominal or urinary tract infections caused by Gram-negative bacteria that were resistant to ceftazidime could not be killed by ceftazidime.
U trećem ispitivanju promatralo se 332 bolesnika s kompliciranim intraabdominalnim infekcijama ili infekcijama mokraćnog sustava uzrokovanim Gram-negativnim bakterijama koje su rezistentne na ceftazidim ceftazidim ih ne ubija.The third study involved 296 women with metastatic disease that got worse despite treatment with other cancer medicines(including anthracyclines and taxanes) and with combinations of cancer medicines plus trastuzumab.
Treće ispitivanje obuhvatilo je 296 žena s metastatskom bolesti čije se stanje pogoršalo usprkos terapiji drugim lijekovima protiv raka(uključujući antracikline i taksane) te kombinacijama lijekova protiv raka i trastuzumaba.In the third study dyspnoea was reported more frequently following Rapiscan(18% for patients with COPD; 11% for patients with asthma) than placebo, but at a lower rate than reported during clinical development see Section 4.8.
U trećem ispitivanju dispneja je prijavljena češće nakon primjene Rapiscana(18% bolesnika s KOBP; 11% bolesnika s astmom) nego placeba, ali s manjom stopom prijava nego tijekom kliničkog razvoja lijeka vidjeti dio 4.8.In the third study, there was a trend for Prialt to be more effective than placebo, with the VASPI score changing from 81 mm before treatment to 68 mm in patients receiving Prialt and to 74 mm in patients receiving placebo.
U trećem ispitivanju bio je prisutan trend da je Prialt bio djelotvorniji od placeba, pri čemu se VASPI rezultat mijenjao od 81 mm prije liječenja do 68 mm u bolesnika koji su primali Prialt te do 74 mm u bolesnika koji su primali placebo.The third study reported no difference in risk of psychiatric adverse events diagnosed during an emergency department visit or inpatient admission between varenicline users and bupropion users HR 0.85; 95% CI: 0.55-1.30.
U trećem ispitivanju nije prijavljena razlika 
